Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G MCHUTCHISON; Eric J LAWITZ; Joseph S GALATI; Bruce R BACON; Mitchell N DAVIS; Pabak MUKHOPADHYAY; Kenneth KOURY; Stephanie NOVIELLO; Lisa D PEDICONE; Clifford A BRASS; Janice K ALBRECHT; Mark S SULKOWSKI; Mitchell L SHIFFMAN; AndrewJ MUIR; Greg W GALLER; Jonathan MCCONE; Lisa M NYBERG; William M LEE; Reem H GHALIB; Eugene R SCHIFF

doi:10.1056/NEJMoa0808010

Back

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

Journal article

Open access

Peer reviewed

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection

John G MCHUTCHISON, Eric J LAWITZ, Joseph S GALATI, Bruce R BACON, Mitchell N DAVIS, Pabak MUKHOPADHYAY, Kenneth KOURY, Stephanie NOVIELLO, Lisa D PEDICONE, Clifford A BRASS, …

The New England journal of medicine, Vol.361(6), pp.580-593

2009

DOI: https://doi.org/10.1056/NEJMoa0808010

PMID: 19625712

Abstract

Antiviral agents

General aspects

Viral hepatitis

Infectious diseases

Pharmacology. Drug treatments

Viral diseases

Biological and medical sciences

Medical sciences

Human viral diseases

Antibiotics. Antiinfectious agents. Antiparasitic agents

Files and links (1)

url

https://doi.org/10.1056/NEJMoa0808010View

Published (Version of record) Open

Metrics

11 Record Views

966 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.125 Hepatitis; 1.125.83 HCV
Web Of Science research areas: Gastroenterology & Hepatology
ESI research areas: Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection
Creators: John G MCHUTCHISON - Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United Kingdom
Eric J LAWITZ - Alamo Medical Research, San Antonio, TX, United States
Joseph S GALATI - Liver Specialists of Texas, Houston, United States
Bruce R BACON - Saint Louis University School of Medicine, St. Louis, United States
Mitchell N DAVIS - South Florida Center of Gastroenterology, Wellington, United States
Pabak MUKHOPADHYAY - Schering-Plough Research Institute, Kenilworth, NJ, United States
Kenneth KOURY - Schering-Plough Research Institute, Kenilworth, NJ, United States
Stephanie NOVIELLO - Schering-Plough Research Institute, Kenilworth, NJ, United States
Lisa D PEDICONE - Schering-Plough Research Institute, Kenilworth, NJ, United States
Clifford A BRASS - Schering-Plough Research Institute, Kenilworth, NJ, United States
Janice K ALBRECHT - Schering-Plough Research Institute, Kenilworth, NJ, United States
Mark S SULKOWSKI - Johns Hopkins University School of Medicine, Baltimore, United States
Mitchell L SHIFFMAN - Virginia Commonwealth University, Richmond, United States
AndrewJ MUIR - Duke Clinical Research Institute and Duke University Medical Center, Durham, NC, United Kingdom
Greg W GALLER - Kelsey Research Foundation, Houston, United States
Jonathan MCCONE - Mount Vernon Endoscopy Center, Alexandria, VA, United States
Lisa M NYBERG - Kaiser Permanente, San Diego Medical Center, San Diego, CA, United States
William M LEE - University of Texas Southwestern Medical Center, Dallas, United States
Reem H GHALIB - Liver Institute at Methodist Dallas Medical Center, Dallas, United States
Eugene R SCHIFF - University of Miami Center for Liver Diseases, Miami, United States
Publication Details: The New England journal of medicine, Vol.361(6), pp.580-593
Publisher: Massachusetts Medical Society; Waltham, MA
Academic Unit: Leadership Department; Miller School of Medicine; UMMG Dept of Medicine - Hepatology
Language: English
Resource Type: Journal article
PMID: 19625712
Record Identifier: 991031562388802976